Menu
Back to User profile » Prof. Dr. Huanxin Lin
Papers published by Prof. Dr. Huanxin Lin:
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial
Chen Y, Li WX, Wu JH, Chen GH, Yang CM, Lu H, Wang X, Wang SS, Huang H, Cai L, Zhao L, Peng RJ, Lin Y, Tang J, Zeng J, Zhang LH, Ke YL, Wang XM, Liu XM, Zhang AQ, Xu F, Bi XW, Huang JJ, Li JB, Pang DM, Xue C, Shi YX, He ZY, Lin HX, An X, Xia W, Cao Y, Guo Y, Hong RX, Jiang KK, Zhong YY, Zhang G, Tienchaiananda P, Oikawa M, Yuan ZY, Chen QJ
Breast Cancer: Targets and Therapy 2024, 16:223-231
Published Date: 12 April 2024
A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Early-Stage Breast Cancer
Hua X, Duan F, Zhai W, Song C, Jiang C, Wang L, Huang J, Lin H, Yuan Z
Journal of Inflammation Research 2022, 15:381-394
Published Date: 16 January 2022
Prognostic impact of the pretreatment albumin to alkaline phosphatase ratio for nonmetastatic breast cancer patients
Long ZQ, Hua X, Zhang WW, Lv SW, Deng JP, Guo L, He ZY, Lin HX
Cancer Management and Research 2019, 11:4809-4814
Published Date: 27 May 2019
Clinicopathologic characteristics and clinical outcomes of pure type and mixed type of tubular carcinoma of the breast: a single-institution cohort study
Zhang WW, Wu SG, Ling YH, Sun JY, Long ZQ, Hua X, Dong Y, Li FY, He ZY, Lin HX
Cancer Management and Research 2018, 10:4509-4515
Published Date: 11 October 2018
Clinicopathological characteristics, treatment, and survival outcomes of cystadenocarcinoma of the salivary gland: a population-based study
Cai CF, Sun JY, He Z, Lin HX, Liu FR, Wang Y
OncoTargets and Therapy 2016, 9:6569-6572
Published Date: 25 October 2016
Differences in esophageal cancer characteristics and survival between Chinese and Caucasian patients in the SEER database
Lin MQ, Li YP, Wu SG, Sun JY, Lin HX, Zhang SY, He ZY
OncoTargets and Therapy 2016, 9:6435-6444
Published Date: 19 October 2016
Progesterone receptor loss identifies hormone receptor-positive and HER2-negative breast cancer subgroups at higher risk of relapse: a retrospective cohort study
Sun JY, Wu SG, Li FY, Lin HX, He ZY
OncoTargets and Therapy 2016, 9:1707-1713
Published Date: 21 March 2016
Prognostic value of lymph node ratio in patients with small-cell carcinoma of the cervix based on data from a large national registry
Zhou J, Sun JY, Chen SY, Li FY, Lin HX, Wu SG, He ZY
OncoTargets and Therapy 2016, 9:67-73
Published Date: 23 December 2015
Effect of blood type on survival of Chinese patients with esophageal squamous cell carcinoma
Qin J, Wu SG, Sun JY, Lin HX, He ZY, Li Q
OncoTargets and Therapy 2015, 8:947-953
Published Date: 23 April 2015